Academic Journal

Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study

التفاصيل البيبلوغرافية
العنوان: Cancer detection rate of prebiopsy MRI with subsequent systematic and targeted biopsy are superior to non-targeting systematic biopsy without MRI in biopsy naïve patients: a retrospective cohort study
المؤلفون: Satoshi Washino, Shigeru Kobayashi, Tomohisa Okochi, Tomohiro Kameda, Tsuzumi Konoshi, Tomoaki Miyagawa, Tatsuya Takayama, Tatsuo Morita
المصدر: BMC Urology, Vol 18, Iss 1, Pp 1-8 (2018)
بيانات النشر: BMC, 2018.
سنة النشر: 2018
المجموعة: LCC:Diseases of the genitourinary system. Urology
مصطلحات موضوعية: Magnetic resonance imaging, Biopsy, Target, Random, Prostate cancer, Diseases of the genitourinary system. Urology, RC870-923
الوصف: Abstract Background To determine whether prebiopsy multiparametric magnetic resonance imaging (mpMRI) with subsequent systematic plus targeted biopsies for suspicious lesions improve prostate cancer detection compared with standard non-targeting systematic biopsies without mpMRI in biopsy-naïve patients. Methods Patients who underwent their first prostate biopsy due to suspicion of prostate cancer were analyzed retrospectively to compare the biopsy outcomes between patients who received prebiopsy mpMRI (215 patients) and those who did not (281 patients). mpMRI was performed to determine pre-biopsy likelihood of the presence of prostate cancer using a three-point scale (1 = low level of suspicion, 2 = equivocal, and 3 = high level of suspicion). Systematic biopsies were performed in both groups. Targeted biopsies were added for a high level of suspicious lesions on mpMRI. All biopsies were performed by transperineal biopsy technique. After biopsy, Prostate Imaging Reporting and Data System ver. 2 (PIRADS-2) scoring was performed to describe the mpMRI findings and predictive value of PIRADS-2 was evaluated. Results The detection rate of total and clinically significant prostate cancer was significantly higher in patients who received prebiopsy mpMRI than in those who did not (55.3 and 46.0% vs. 42.0 and 35.2%, respectively; p = 0.004 and p = 0.016). The clinically insignificant prostate cancer detection rate was similar between the two groups (9.3% vs. 6.8%; p = 0.32). Of 86 patients who underwent systematic plus targeted biopsy in the MRI cohort and were diagnosed with prostate cancer, seven patients were detected by addition of targeted biopsy whereas 29 patients were missed by targeted biopsy but detected by systematic biopsy. There was a correlation between the PIRADS-2 and prostate cancer detection rate, and a receiver-operator curve analysis yielded an area under the curve of 0.801 (p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2490
Relation: http://link.springer.com/article/10.1186/s12894-018-0361-4; https://doaj.org/toc/1471-2490
DOI: 10.1186/s12894-018-0361-4
URL الوصول: https://doaj.org/article/9a418fedbe424a419ae03b075a2f575e
رقم الانضمام: edsdoj.9a418fedbe424a419ae03b075a2f575e
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712490
DOI:10.1186/s12894-018-0361-4